Obesity and Serious Mental Ill Health: A Critical Review of the Literature

被引:43
作者
Bradshaw, Tim [1 ]
Mairs, Hilary [1 ]
机构
[1] Univ Manchester, Sch Nursing Midwifery & Social Work, Mental Hlth Nursing, Oxford Rd, Manchester M13 9PL, Lancs, England
来源
HEALTHCARE | 2014年 / 2卷 / 02期
关键词
serious mental illness; obesity; physical health;
D O I
10.3390/healthcare2020166
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Individuals who experience serious mental ill health such as schizophrenia are more likely to be overweight or obese than others in the general population. This high prevalence of obesity and other associated metabolic disturbances, such as type 2 diabetes and cardiovascular disease, contribute to a reduced life expectancy of up to 25 years. Several reasons have been proposed for high levels of obesity including a shared biological vulnerability between serious mental ill health and abnormal metabolic processes, potentially compounded by unhealthy lifestyles. However, emerging evidence suggests that the most significant cause of weight gain is the metabolic side effects of antipsychotic medication, usual treatment for people with serious mental ill health. In this paper we review the prevalence of obesity in people with serious mental ill health, explore the contribution that antipsychotic medication may make to weight gain and discuss the implications of this data for future research and the practice of mental health and other professionals.
引用
收藏
页码:166 / 182
页数:17
相关论文
共 55 条
  • [1] Weight gain in first-episode psychosis over three years
    Addington, Jean
    Saeedi, Huma
    Addington, Donald
    [J]. SCHIZOPHRENIA RESEARCH, 2006, 86 (1-3) : 335 - 336
  • [2] A Double Blind, Placebo-Controlled, Randomized Crossover Study of the Acute Metabolic Effects of Olanzapine in Healthy Volunteers
    Albaugh, Vance L.
    Singareddy, Ravi
    Mauger, David
    Lynch, Christopher J.
    [J]. PLOS ONE, 2011, 6 (08):
  • [3] Allison DB, 1999, AM J PSYCHIAT, V156, P1686
  • [4] Non-pharmacological management of anti psychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials
    Alvarez-Jimenez, Mario
    Hetrick, Sarah E.
    Gonzalez-Blanch, Cesar
    Gleeson, John F.
    McGorry, Patrick D.
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2008, 193 (02) : 101 - 107
  • [5] Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders -: A systematic critical reappraisal
    Alvarez-Jimenez, Mario
    Gonzalez-Blanch, Cesar
    Crespo-Facorro, Benedicto
    Hetrick, Sarah
    Rodriguez-Sanchez, Jose Manuel
    Perez-Iglesias, Rocio
    Vazquez-Barquero, Jose Luis
    [J]. CNS DRUGS, 2008, 22 (07) : 547 - 562
  • [6] Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients:: A randomized controlled trial
    Alvarez-Jimenez, Mario
    Gonzalez-Blanch, Cesar
    Vazquez-Barquero, Jose Luis
    Perez-Iglesias, Rocio
    Martinez-Garcia, Obdulia
    Perez-Pardal, Teresa
    Ramirez-Bonilla, Mari Luz
    Crespo-Facorro, Benedicto
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (08) : 1253 - 1260
  • [7] Andreasen N.C., 1984, SCALE ASSESSMENT POS
  • [8] [Anonymous], 2011, LANCET, V377, P611, DOI 10.1016/S0140-6736(11)60211-0
  • [9] [Anonymous], 1984, SCALE ASSESSMENT POS
  • [10] Berenson A., ELI LILLY SAID PLAY